Clinical Trials Directory

Trials / Conditions / Stage IVB Fallopian Tube Cancer AJCC v8

Stage IVB Fallopian Tube Cancer AJCC v8

10 registered clinical trials studyying Stage IVB Fallopian Tube Cancer AJCC v8 — 4 currently recruiting.

StatusTrialSponsorPhase
WithdrawnSpecialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients W
NCT03735589
Roswell Park Cancer InstitutePhase 1 / Phase 2
RecruitingHyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Tr
NCT05415709
Ohio State University Comprehensive Cancer CenterEARLY_Phase 1
RecruitingPhase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Pa
NCT05092373
M.D. Anderson Cancer CenterPhase 1
WithdrawnAbexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer
NCT04498520
Pamela MunsterPhase 1
RecruitingMinimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary
NCT04575935
M.D. Anderson Cancer CenterPhase 3
RecruitingTalazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
NCT03968406
M.D. Anderson Cancer CenterPhase 1
Active Not RecruitingOlaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cance
NCT03943173
M.D. Anderson Cancer CenterEARLY_Phase 1
Active Not RecruitingModified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistan
NCT03907527
Precigen, IncPhase 1
CompletedNivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With
NCT03508570
M.D. Anderson Cancer CenterPhase 1
Active Not RecruitingGene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY
NCT02650986
Roswell Park Cancer InstitutePhase 1 / Phase 2